Clinical trial
EMLA 5% as a Treatment for Tinnitus and Its Accompanied Symptoms
NCT02266160 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EMLA 5% as a Treatment for Tinnitus and Its Accompanied Symptoms
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- December 31, 2015
- Enrollment
- 142 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.